Longitudinal Multi-Omics Analysis Service

What is Longitudinal Multi-Omics?

Longitudinal multi-omics is a systems biology approach that profiles multiple molecular layers (e.g., proteome, metabolome, microbiome) from the same individuals across multiple time points. Unlike cross-sectional studies that provide a single snapshot, longitudinal profiling captures within-individual temporal change, enabling detection of time-ordered molecular variation, identification of co-moving pathways, and exploration of microbiome–host coupling dynamics over time.

Importantly, longitudinal association patterns can suggest directionality-informed hypotheses (e.g., microbial changes preceding metabolite shifts), but they do not constitute proof of causation. Results are intended for research interpretation and downstream validation studies.

Problems We Can Solve

Longitudinal cohorts face unique technical and analytical hurdles. We convert these challenges into reproducible discovery workflows:

Time-Window Discovery (vs. Missing Early Molecular Changes)

Challenge: Subtle molecular changes may occur before clear phenotypic shifts are observable in cohort metadata, and can be missed in static comparisons.

Solution: We generate trajectory curves, turning-point candidates, and leading-change feature lists to highlight time windows where molecular changes emerge—supporting research hypothesis generation and follow-up validation experiments.

Batch Harmonization Across Months/Years (vs. Technical Drift)

Challenge: Multi-year collections amplify instrument drift and batch-to-batch variability, potentially masking biology.

Solution: We implement study-pool QC and bridging reference samples across all batches. You receive concrete QC evidence (drift curves, PCA stability, missingness, and reproducibility metrics) demonstrating cross-batch comparability after correction.

Integration Interpretability (vs. Multi-Omics Complexity)

Challenge: Connecting microbiome features with blood or stool metabolites over time requires careful modeling and robust QC.

Solution: We provide cross-omics association matrices (including time-lag exploration where appropriate) and pathway summaries that connect microbes, metabolites, and host proteins into interpretable mechanisms for scientific discussion.

Service Scope and Study Options for Longitudinal Cohorts

We provide modular, cohort-ready services for repeated-measures time-series studies. Choose the track aligned with your primary scientific objective; tracks can be combined as needed.

Track 1 — Longitudinal Metabolomics (Time-Series Phenotyping)

Best for: large cohorts, multiple time points, temporal pattern discovery, intervention-response research designs.

• Metabolomics profiling across time points: untargeted discovery and/or targeted panels for consistent tracking.
• Longitudinal comparability support: study-pool QC + bridging references + drift monitoring/correction.
• Time-series analysis outputs: trends, turning-point candidates, subgroup trajectories.
• Typical matrices: plasma/serum/urine (feces optional).
• Recommended time points: ≥3 (2 supports pre/post analysis).

Track 2 — Host Biology Longitudinal Multi-Omics (Proteome + Metabolome)

Best for: host pathway interpretation, immune-metabolic research, longitudinal response profiling.

• DIA proteomics time-series profiling: high-coverage protein quantification with DIA acquisition.
• Metabolomics time-series profiling: untargeted and/or targeted.
• Cross-omics integration: protein–metabolite covariation, pathway timeline summaries, key-axis shortlists.
• Longitudinal QC package: pre/post harmonization diagnostics for multi-batch studies.
• Typical matrices: plasma/serum/urine.
• Recommended time points: ≥3.

Track 3 — Microbiome–Host Longitudinal Multi-Omics (Microbiome + Metabolome ± Proteome)

Best for: microbiome-driven hypotheses, diet/probiotic/antibiotic research designs, host–microbe coupling exploration.

• Microbiome profiling: 16S rRNA sequencing or shotgun metagenomics across time points.
• Metabolomics profiling: plasma/serum/urine and/or feces (study-design dependent).
• Optional proteomics layer: for deeper host mechanism context.
• Integration outputs: cross-omics associations (optionally with time-lag exploration), networks, hub features, and pathway summaries.
• Typical matrices: stool + plasma/serum (urine optional).
• Recommended time points: ≥3.

Included in Every Track (Baseline Service Components)

• Study design input: time-point structure, matrix selection, metadata checklist, and confounder planning guidance (research context).
• Longitudinal QC architecture: study-pool QC, bridging references, drift monitoring/correction, and QC evidence reporting.
• Time-series analytics core: trajectories/trends, subgrouping, cross-omics associations, and pathway/network interpretation.
• Reproducible delivery package: normalized matrices, QC appendix, and methods documentation.

Analyte Coverage and Typical Depth

Coverage varies by matrix, cohort design, and depth settings. Typical ranges below are commonly observed for biofluids (plasma/serum) under standard configurations.

Why Choose Our Longitudinal Multi-Omics Service

• Experienced multi-omics operations: Established workflows for complex cohort biospecimens and multi-layer integration (RUO).
• Longitudinal QC-first design: Acceptance criteria are defined per platform/matrix; typical targets include pooled-QC reproducibility (e.g., median RSD around ≤20% where feasible) with transparent reporting of batch behavior.
• End-to-end pipeline: From sample handling guidance to analytics and interpretation—reducing cross-vendor variability and handoff risk.
• Deep longitudinal analytics: Trajectory clustering, time-lag exploration, and network/pathway interpretation to contextualize "what changes with time" and "what changes together."

Project Workflow for Longitudinal Multi-omics Profiling

1

Cohort Design Consultation (RUO)

Define time points, sample size (commonly N ≥ 30 as a practical starting point; study-dependent), and metadata templates.

2

Sampling & Banking Guidance

Standardize collection conditions (tube type, fasting status, time-of-day, processing time) to reduce noise.

3

Unified Extraction Strategy

Standardized SOPs for metabolites/proteins/DNA from coordinated aliquots where applicable.

4

Multi-Platform Acquisition

Randomized run order with embedded study-pool QCs and bridging references.

5

Harmonization & Processing

Drift modeling, normalization, and batch harmonization with diagnostic reporting.

6

Time-Series Analytics

Trajectory grouping, association mining (including time-lag exploration when appropriate), and network/pathway interpretation.

Longitudinal multi-omics workflow: cohort time points to biobanking, advanced platforms, integration, and bioinformatics insights.

Analytical Platforms for Longitudinal Multi-omics Profiling

We use high-performance platforms optimized for longitudinal stability. Specific configurations may vary by study design and matrix.

Instrumentation (Typical)

• Metabolomics: Triple quadrupole and/or Orbitrap HRAM for targeted/untargeted applications.
• Proteomics: Orbitrap-based DIA acquisition for stable quantification and reduced missingness.
• Sequencing: Illumina platforms for 16S and shotgun metagenomics (depth and read length per study).

Longitudinal Batch Control Framework

Bridging References: A consistent reference material run across all batches (month 1 to month N) to enable cross-batch modeling.

QC Benchmarks (Study-Dependent):

• Drift monitoring & correction: Methods selected based on QC behavior (e.g., LOESS-type approaches; SERRF-like strategies when appropriate).
• Reproducibility targets: Pooled-QC RSD goals defined per platform/matrix; reported with distributions and batch-level pass/fail rationale.
• Retention time alignment: Alignment windows defined per method; reported with pre/post alignment diagnostics.

Sample Types & Submission Requirements

Core Principle: Keep collection conditions consistent within the cohort to minimize non-biological variability.

Deliverables: What You Receive from Our Service

• Processed Data Tables (CSV/XLSX): harmonized metabolomics/proteomics/microbiome matrices + sample/time-point mapping.
• QC & Harmonization Report (PDF): bridging QC design, drift/batch correction evidence (PCA, drift curves, RSD/missingness).
• Longitudinal Analysis Results (CSV/XLSX): trajectory/trend statistics, clustering (if applied), key feature lists.
• Multi-Omics Integration Outputs (CSV): cross-omics association matrices; networks (Cytoscape-ready) if requested.
• Figures (PNG + editable PDF/SVG): key plots for publication and presentations.
• Methods Appendix (PDF/DOCX): brief methods + parameter summary for reproducibility

Bridging QC stabilizes longitudinal metabolomics signals by correcting run-order drift across batches.

Time-series trajectory clustering reveals distinct longitudinal multi-omics patterns across cohort follow-up.

Cross-omics network and pathway timeline summarize microbiome–proteome–metabolome co-variation over time.

Time-lag associations identify microbiome shifts that precede metabolomics changes in longitudinal cohorts.

Longitudinal Multi-Omics Applications and Use Cases